Blockade of LAG-3 in PD-L1-deficient mice enhances clearance of blood stage malaria independent of humoral responses
Abstract T cells expressing high levels of inhibitory receptors such as PD-1 and LAG-3 are a hallmark of chronic infections and cancer. Checkpoint blockade therapies targeting these receptors have been largely validated as promising strategies to restore exhausted T cell functions and clearance of chronic infections and tumors. The inability to develop long-term natural immunity in malaria-infected patients has been proposed to be at least partially accounted for by sustained expression of high levels of inhibitory receptors on T and B lymphocytes. While blockade or lack of PD-1/PD-L1 and/or LAG-3 was reported to promote better clearance ofPlasmodiumparasites in mice, how exactly these pathways contributes to protection is not known. Herein, using a mouse model of non-lethalP. yoelii (Py)infection, we reveal that the kinetics of blood parasitemia is indistinguishable between PD-1-/-, PD-L1-/-and WT mice. Yet, monoclonal antibody (mAb) blockade of LAG-3 in PD-L1-/-mice promoted accelerated control of blood parasite growth and clearance. We also report that i) the majority of LAG-3+cells are T cells, ii) selective depletion of CD8+T cells did not prevent anti-LAG-3-mediated protection, and iii) production of effector cytokines by CD4+T cells is increased in anti-LAG-3-treated versus control mice. In addition, parasite-specific Ab serum titers and their ability to transfer protection from both groups of mice was comparable and depletion of CD4+T cells prevented protection. Thus, taken together, these results are consistent with a model in which disruption of PD-L1 and LAG-3 on parasite-specific CD4+T cells unleashes their ability to effectively clear blood parasites, independently from humoral responses.Author Summary Malaria, caused byPlasmodiumparasites, is a global burden for which an efficacious vaccine is urgently needed. The development of long-term immunity against malaria is unclear, but we know that both T and B (that produce antibodies, Ab) lymphocytes, that are subsets of white blood cells, are required. Studies in mouse models of malaria have suggested that sets of inhibitory receptors, namely LAG-3 and PD-1, expressed on cytotoxic and helper T lymphocytes hamper the development of effective immunity against malaria. Therapeutic blockade of these receptors was reported to enhance blood parasite clearance through the development of more protective parasite-specific helper T lymphocytes and Abs. Herein, we reveal that, while mice genetically deficient for the PD-1 pathway fail to clear blood parasites better than WT counterparts, anti-LAG-3 treatment does. Importantly, we found comparable parasite-specific Ab responses between all mouse groups, and Ab transfers conferred similar protection to newly infected mice. We also show that LAG-3 is mostly expressed on T lymphocytes, and that cytotoxic T lymphocytes are not involved in anti-LAG-3 accelerated clearance of parasites. Our results suggest that LAG-3 blockade acts on helper T lymphocytes to unleash their effector responses and enhance the control of blood-stage malaria, independently from parasite-specific Abs..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
bioRxiv.org - (2023) vom: 02. Okt. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Furtado, Raquel [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
doi: |
10.1101/2020.06.22.164566 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI018191134 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI018191134 | ||
003 | DE-627 | ||
005 | 20231205150504.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200624s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2020.06.22.164566 |2 doi | |
035 | |a (DE-627)XBI018191134 | ||
035 | |a (biorXiv)10.1101/2020.06.22.164566 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Furtado, Raquel |e verfasserin |0 (orcid)0000-0002-7442-0767 |4 aut | |
245 | 1 | 0 | |a Blockade of LAG-3 in PD-L1-deficient mice enhances clearance of blood stage malaria independent of humoral responses |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract T cells expressing high levels of inhibitory receptors such as PD-1 and LAG-3 are a hallmark of chronic infections and cancer. Checkpoint blockade therapies targeting these receptors have been largely validated as promising strategies to restore exhausted T cell functions and clearance of chronic infections and tumors. The inability to develop long-term natural immunity in malaria-infected patients has been proposed to be at least partially accounted for by sustained expression of high levels of inhibitory receptors on T and B lymphocytes. While blockade or lack of PD-1/PD-L1 and/or LAG-3 was reported to promote better clearance ofPlasmodiumparasites in mice, how exactly these pathways contributes to protection is not known. Herein, using a mouse model of non-lethalP. yoelii (Py)infection, we reveal that the kinetics of blood parasitemia is indistinguishable between PD-1-/-, PD-L1-/-and WT mice. Yet, monoclonal antibody (mAb) blockade of LAG-3 in PD-L1-/-mice promoted accelerated control of blood parasite growth and clearance. We also report that i) the majority of LAG-3+cells are T cells, ii) selective depletion of CD8+T cells did not prevent anti-LAG-3-mediated protection, and iii) production of effector cytokines by CD4+T cells is increased in anti-LAG-3-treated versus control mice. In addition, parasite-specific Ab serum titers and their ability to transfer protection from both groups of mice was comparable and depletion of CD4+T cells prevented protection. Thus, taken together, these results are consistent with a model in which disruption of PD-L1 and LAG-3 on parasite-specific CD4+T cells unleashes their ability to effectively clear blood parasites, independently from humoral responses.Author Summary Malaria, caused byPlasmodiumparasites, is a global burden for which an efficacious vaccine is urgently needed. The development of long-term immunity against malaria is unclear, but we know that both T and B (that produce antibodies, Ab) lymphocytes, that are subsets of white blood cells, are required. Studies in mouse models of malaria have suggested that sets of inhibitory receptors, namely LAG-3 and PD-1, expressed on cytotoxic and helper T lymphocytes hamper the development of effective immunity against malaria. Therapeutic blockade of these receptors was reported to enhance blood parasite clearance through the development of more protective parasite-specific helper T lymphocytes and Abs. Herein, we reveal that, while mice genetically deficient for the PD-1 pathway fail to clear blood parasites better than WT counterparts, anti-LAG-3 treatment does. Importantly, we found comparable parasite-specific Ab responses between all mouse groups, and Ab transfers conferred similar protection to newly infected mice. We also show that LAG-3 is mostly expressed on T lymphocytes, and that cytotoxic T lymphocytes are not involved in anti-LAG-3 accelerated clearance of parasites. Our results suggest that LAG-3 blockade acts on helper T lymphocytes to unleash their effector responses and enhance the control of blood-stage malaria, independently from parasite-specific Abs. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Chorro, Laurent |4 aut | |
700 | 1 | |a Zimmerman, Natalie |0 (orcid)0000-0002-5146-8899 |4 aut | |
700 | 1 | |a Guillen, Erik |0 (orcid)0000-0001-7873-829X |4 aut | |
700 | 1 | |a Spaulding, Emily |4 aut | |
700 | 1 | |a Chin, Shu Shien |0 (orcid)0000-0002-2455-9533 |4 aut | |
700 | 1 | |a Daily, Johanna P. |4 aut | |
700 | 1 | |a Lauvau, Grégoire |0 (orcid)0000-0002-3050-2664 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 02. Okt. |
773 | 1 | 8 | |g year:2023 |g day:02 |g month:10 |
856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2020.576743 |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.06.22.164566 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
951 | |a AR | ||
952 | |j 2023 |b 02 |c 10 |